# Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty

> **NCT01630941** · PHASE2 · COMPLETED · sponsor: **Hans Mallmin** · enrollment: 64 (actual)

## Conditions studied

- Osteoarthritis, Hip
- Ambulation Difficulty

## Interventions

- **DRUG:** denosumab

## Key facts

- **NCT ID:** NCT01630941
- **Lead sponsor:** Hans Mallmin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08-07
- **Primary completion:** 2017-01-16
- **Final completion:** 2017-03-30
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2017-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01630941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01630941, "Effects of Denosumab on Periprosthetic Bone After Total Hip Arthroplasty". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01630941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*